Bottom line
KURE vs IDEV: the short answer
KURE (KraneShares MSCI All China Health Care Index ETF) and IDEV (iShares Core MSCI International Developed Markets ETF) are both etfs.
But IDEV is far broader, holding 2,337 positions to 63 for KURE, so beyond the top names it adds exposure KURE doesn't have.
IDEV is cheaper at 0.04% vs 0.65% — a difference of $61 a year per $10,000 invested.
Over five years, IDEV returned +5.0% a year vs −11.8% for KURE (reporting dates differ).
Updated Nov 19, 2026
KURE vs IDEV side by side
| KURE | IDEV | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Krane Shares | iShares |
| Category | Health Care Sector | International Stock |
| Expense ratio | 0.65% | 0.04% |
| Annual cost per $10k | $65 | $4 |
| 10-yr cost on $10k (prospectus) | $951 | $51 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +24.8% | +4.5% |
| 5-yr return (annualized) | −11.8% | +5.0% |
| 10-yr return (annualized) | — | — |
| Best quarter | +33.4% | +16.9% |
| Worst quarter | −23.4% | −24.0% |
| Net assets (fund) | $71.2M | $31.6B |
| Number of holdings | 63 | 2,337 |
| Portfolio turnover | 73% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | KURE | IDEV | Difference |
|---|---|---|---|
| 2024 | −17.4% | +4.5% | −21.9% |
| 2023 | −17.3% | +17.3% | −34.6% |
| 2022 | −25.4% | −14.9% | −10.5% |
| 2021 | −15.9% | +12.7% | −28.6% |
| 2020 | +67.3% | +8.4% | +58.9% |
| 2019 | +34.0% | +23.4% | +10.6% |
Source: Fund prospectus bar charts
Holdings overlap
KURE and IDEV share none of their top holdings.
KURE top 10
- BeOne Medicines AG — 8.84%
- Innovent Biologics, Inc. — 8.80%
- Wuxi Biologics (cayman) Inc. — 7.51%
- WuXi AppTec Co., Ltd. — 5.79%
- Jiangsu Hengrui Pharmaceuticals Co.,Ltd — 4.59%
- Shenzhen Mindray Bio-Medical Electronics Co Ltd — 4.27%
- Akeso Inc — 3.72%
- Cspc Pharmaceutical Group Limited — 3.68%
- Invesco Government & Agency Portfolio — 3.55%
- Sino Biopharmaceutical Limited — 3.39%
IDEV top 10
- ASML Holding N.V. — 2.19%
- Hsbc Holdings Plc — 1.24%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.16%
- Roche Holding AG — 1.05%
- Royal Bank Of Canada — 1.00%
- Novartis AG — 0.98%
- Astrazeneca Plc — 0.88%
- Nestle S.A. — 0.88%
- Shell Plc — 0.88%
- Siemens Aktiengesellschaft — 0.83%
FAQ
What is the difference between KURE and IDEV?
Which is cheaper, KURE or IDEV?
Should I own both KURE and IDEV?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.